Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG. (Q39649952)
Jump to navigation
Jump to search
scientific article published on 14 February 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG. |
scientific article published on 14 February 2012 |
Statements
Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG (English)
Marc A Vos
Göran Duker
Peter Sartipy
Toon A B van Veen
14 February 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference